An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant.

It is believed that Rb blocks G1-S transition by inhibiting expression of E2F regulated genes. Here, we report that the effects of E2F repression lag behind the onset of G1 cell cycle arrest in timed Rb reexpression experiments. In comparison, kinase inhibitor p27Kip1 protein accumulates with a faster kinetics. Conversely, Rb knockout leads to faster p27 degradation. Rb interacts with the N terminus of Skp2, interferes with Skp2-p27 interaction, and inhibits ubiquitination of p27. Disruption of p27 function or expression of the Skp2 N terminus prevents Rb from causing G1 arrest. A full-penetrance, inactive Rb mutant fails to interfere with Skp2-p27 interaction but, interestingly, a partial-penetrance Rb mutant that is defective for E2F binding retains full activity in inhibiting Skp2-p27 interaction and can induce G1 cell cycle arrest with wild-type kinetics. These results identify an Rb-Skp2-p27 pathway in Rb function, which may be involved in inhibition of tumor progression.

[1]  Hong Sun,et al.  p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27 , 1999, Current Biology.

[2]  Liang Zhu,et al.  Requirement of Cyclin E-Cdk2 Inhibition in p16INK4a-Mediated Growth Suppression , 1998, Molecular and Cellular Biology.

[3]  R. Mamillapalli,et al.  PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27KIP1 through the ubiquitin E3 ligase SCFSKP2 , 2001, Current Biology.

[4]  P. Guida,et al.  pRB and p107 have distinct effects when expressed in pRB-deficient tumor cells at physiologically relevant levels , 2000, Oncogene.

[5]  M. Pagano,et al.  Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. , 2004, Nature.

[6]  James M. Roberts,et al.  The murine gene p27Kip1 is haplo-insufficient for tumour suppression , 1998, Nature.

[7]  A. Shvarts,et al.  Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. , 1996, Genes & development.

[8]  Michele Pagano,et al.  Deregulated degradation of the cdk inhibitor p27 and malignant transformation. , 2003, Seminars in cancer biology.

[9]  M. Pagano,et al.  Role of the F-box protein Skp2 in lymphomagenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Helin,et al.  Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry , 2002, Nature Genetics.

[11]  M. Kitagawa,et al.  Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication , 2000, The EMBO journal.

[12]  S. Reed,et al.  Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover , 2003, Nature Reviews Molecular Cell Biology.

[13]  Michele Pagano,et al.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 , 1999, Nature Cell Biology.

[14]  Hong Sun,et al.  Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate. , 2003, Cancer research.

[15]  J. Harbour,et al.  The Rb/E2F pathway: expanding roles and emerging paradigms. , 2000, Genes & development.

[16]  S. Reed,et al.  The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). , 2002, Genes & development.

[17]  C. Cordon-Cardo,et al.  p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Flemington,et al.  Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Livingston,et al.  The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. , 1996, Genes & development.

[20]  R. Weinberg,et al.  Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts , 1996, Molecular and cellular biology.

[21]  Jean Y. J. Wang,et al.  Growth Suppression by an E2F-Binding-Defective Retinoblastoma Protein (RB): Contribution from the RB C Pocket , 1998, Molecular and Cellular Biology.

[22]  James M. Roberts,et al.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.

[23]  S. Reed,et al.  Activation of cyclin E/CDK2 is coupled to site‐specific autophosphorylation and ubiquitin‐dependent degradation of cyclin E. , 1996, The EMBO journal.

[24]  Frank McCormick,et al.  Proliferation of cancer cells despite CDK2 inhibition. , 2003, Cancer cell.

[25]  James M. Roberts,et al.  A new pathway for mitogen-dependent Cdk2 regulation uncovered in p27Kip1-deficient cells , 1999, Current Biology.

[26]  James M. Roberts,et al.  Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. , 1996, Genes & development.

[27]  Michele Pagano,et al.  Control of the SCFSkp2–Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligase , 2004, Nature.

[28]  J. Mestan,et al.  Skp2 is oncogenic and overexpressed in human cancers , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Wilhelm Krek,et al.  p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells , 1999, Nature Cell Biology.

[30]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[31]  M. Pagano,et al.  Cell cycle regulation by the ubiquitin pathway , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  F. Kaye,et al.  Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  James M. Roberts,et al.  A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase , 2001, Nature.

[34]  Guo-Jun Zhang,et al.  Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex , 2004, Nature.

[35]  P. Hinds,et al.  Requirement for p27KIP1 in Retinoblastoma Protein-Mediated Senescence , 2001, Molecular and Cellular Biology.

[36]  Michele Pagano,et al.  Role of the F-Box Protein Skp2 in Adhesion-Dependent Cell Cycle Progression , 2001, The Journal of cell biology.

[37]  M. Vidal,et al.  Identification of a family of human F-box proteins , 1999, Current Biology.

[38]  James M. Roberts,et al.  Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. , 2003, Molecular cell.

[39]  W. Sellers,et al.  Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. , 1998, Genes & development.

[40]  Tohru Natsume,et al.  Skp2-mediated degradation of p27 regulates progression into mitosis. , 2004, Developmental cell.

[41]  L. Naldini,et al.  Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. , 2002, Human gene therapy.